For example, some AIFCM (e.g., triptolide, CPT and dihydroartemisinin) with PDT can inhibit tumor hypoxia and treatment resistance by down-regulating HIF-1α and promoting ROS generation 157, 159, 160. The gene discussed is HIF1A; the disease is neoplasm.